96413

Chemotherapy administration, intravenous infusion, up to 1 hour

This procedure involves the intravenous administration of antineoplastic agents (chemotherapy) or other complex drugs for the treatment of various cancers or specific non-oncological conditions. It includes the preparation of the medication, establishment or verification of intravenous access, infusion of the drug over a period up to one hour, and continuous monitoring of the patient for adverse reactions. This code represents the initial or single chemotherapy drug administered via intravenous infusion.

Clinical Indications

  • Treatment of solid tumors (e.g., breast cancer, lung cancer, colorectal cancer, ovarian cancer)
  • Treatment of hematologic malignancies (e.g., leukemia, lymphoma, multiple myeloma)
  • Adjuvant therapy to reduce the risk of recurrence after primary treatment (e.g., surgery)
  • Neoadjuvant therapy to shrink tumors before primary treatment
  • Palliative treatment for advanced or metastatic disease to manage symptoms and prolong life
  • Specific non-oncological conditions where complex drug infusions are classified under chemotherapy administration due to their complexity or toxicity

Procedure Steps

  1. Patient assessment, including review of medical history, current condition, and laboratory results
  2. Obtaining informed consent and educating the patient about the chemotherapy regimen, potential side effects, and administration process
  3. Establishing and verifying appropriate intravenous access (e.g., peripheral IV, central venous catheter, port-a-cath)
  4. Sterile preparation of the chemotherapy drug(s) according to physician orders and established guidelines
  5. Administration of pre-medications (e.g., antiemetics, antihistamines, corticosteroids) as prescribed
  6. Initiation and continuous monitoring of the intravenous infusion of the antineoplastic agent
  7. Monitoring patient's vital signs and observing for infusion reactions, extravasation, and other adverse effects throughout the infusion period
  8. Post-infusion care, including flushing the IV line, safe disconnection, and providing post-procedure instructions
  9. Comprehensive documentation of the procedure, medications administered, start/stop times, patient response, and any adverse events

Coding Guidelines

  • Code 96413 is for the initial or single intravenous infusion of a chemotherapy substance lasting up to 1 hour.
  • For additional hours of infusion of the same chemotherapy drug, use add-on code 96415.
  • Do not bill 96413 for infusions lasting less than 16 minutes; these may be coded as intravenous pushes (96409-96411) if applicable.
  • Only one initial chemotherapy administration code (e.g., 96413, 96409, 96420) should be reported per encounter for each unique route of administration, unless specific criteria for separate primary services are met.
  • Hydration (96360-96361) or other therapeutic infusions (96365-96368) administered before or after chemotherapy can be billed separately if they meet independent time and medical necessity requirements.
  • Concurrent hydration or antiemetics given during chemotherapy infusion are generally considered incidental to the chemotherapy administration unless distinct qualifying criteria are met for separate billing.
  • Detailed documentation of the specific drug, dosage, route, start and stop times, total duration of infusion, and patient monitoring is essential to support billing.
  • Modifier -59 (Distinct Procedural Service) may be necessary to indicate distinct services when multiple types of infusions or injections are performed during the same encounter.

Associated ICD-10 Codes